Gap junctions between vessel wall cells provide a pathway for the intercellular exchange of ions and small molecules. Pure 
G ap junctions are membrane structures that contain aqueous channels linking the cytoplasm of adjacent cells.1,2 These structures are responsible for electrotonic coupling, equilibration of ionic and small molecular pools between coupled cells, and coordination of tissue responses to stimuli. Electron microscopic studies have demonstrated gap junctions between vascular wall cells throughout the vascular tree.2 We2-4 and others5 have previously shown evidence of junctional transfer of small molecules in the vessel wall in situ. Therefore, gap junctions exist between cells in the vessel wall and appear to be functional.
In culture, endothelial cells, smooth muscle cells, and pericytes all produce gap junctions and engage in junctional transfer among themselves.2,6-8 In addi-tion, these cells are capable of producing functional gap junctions between cell types.2-5'9 In the vessel wall, heterocellular communication has also been detected. [3] [4] [5] Recent biochemical and molecular studies have demonstrated that there is a family of related gap junction proteins called connexins. Well-characterized mammalian connexins include connexin43 (the "heart" gap junction protein)10-'3 and connexin32 and connexin26 ("liver" proteins).14-'7 In addition, complementary DNAs for connexin26, connexin32, and connexin43 have been cloned.12"5"17 Each of the proteins is expressed in a wide variety of tissues. The transmembrane and extracellular domains of these connexins are similar, suggesting that they form similar gap junction structures. However, they each also have unique cytoplasmic domains that may confer physiological specificity in different cells. It is not known which type(s) of gap junction proteins comprises the specific vascular junctions and whether they vary with vascular cell type, vascular bed, or species.
Therefore, the goals of the current study were to answer the following questions: Are there cell, vessel, or species differences in the capability of 
Tissue Preparations
Tissues were used to check on the in vivo expression of junctional messenger RNA (mRNA), where possible (see References 12, 15, and 16) . Bovine or rat heart tissue RNA samples were used as positive controls for connexin43. Rat liver RNA samples were a positive control for connexin26 and connexin32.
The prime criterion for the studies on the vessel wall was collection of an essentially pure cell type. Living "Hautchen" preparations from bovine aortas were razor-blade intimal scrapings. This is the initial step in the usual culture procedure for bovine aortic endothelial cells and yields a nearly pure population of endothelium. Rat aortic medial preparations, cleaned of adventitia by dissection and of intima by scraping, were used as a pure source of smooth muscle cells.
Dye Transfer Assays
We have previously demonstrated junctional transfer in several of the cell types tested in this study ( 
Dye Transfer
The dye transfer assays were carried out on cultures grown in parallel to those used for mRNA isolation. All of the vascular cells tested were capable of dye transfer (Table 1 ). Figure 1 demonstrates examples of these results for scrape-loaded human umbilical vein endothelial cells and microinjected rat aortic smooth muscle cells and bovine brain microvascular pericytes. Of the nonvascular cells tested, IMR-90 fibroblasts and AR42J were capable of dye transfer, but C6 glioma, T84, and sarcoma 180 cells (Figure 1 ) did not demonstrate detectable transfer when using either the scrape-load or direct microinjection assays. MDCK cells were not tested; however, MDCK cells have been shown by others not to engage in junctional transfer33 or to do so to only a limited extent.34 L929 fibroblasts were not tested in these studies; we679 and others35 have previously (Figure 3) but not for connexin32. Connexin26 mRNA was detected in RNA from AR42J cells but not from L929 or C6 cells.
Tissue preparations. Since connexin43 was originally isolated from heart and since connexin26 and connexin32 were originally isolated from liver, total RNA preparations from those tissues were used as positive or negative control samples for expression of the respective connexin mRNAs.
To verify that the exclusive expression of connexin43 mRNA by all of the cultured vascular cells did not present a phenotypic change due to adaptation to cell culture, we performed Northern blots of RNA extracted from fresh bovine aortic Hautchen and rat aortic medial preparations (Figure 4 ). These blots revealed that both endothelium and smooth muscle also express mRNA for connexin43 in vivo. Neither preparation contained detectable connexin32 or connexin26 message (not shown). The identification of an additional connexin ex- pressed by these cells would not invalidate the present findings but would add to the levels of complexity; in one possible scenario, cells of all vascular types could communicate via connexin43, but those of one type might have some communication specificity conferred by the expression of a second connexin.
Several cultured nonvascular cell types were tested as controls for the expression of connexin mRNA in vascular cells. In general, we found that connexin32 and connexin26 mRNAs were detectable in the tested cultures of epithelial origin whereas connexin43 mRNA was present in fibroblasts and sarcoma and glioma lines (as well as the vascular cells).
None of the cell types tested contained both connexin43 and connexin32 or connexin26.
Finally, this study has raised an interesting new issue. Several nonvascular cell types (sarcoma 180, L929, C6 glioma), which communicate poorly (or not at all), expressed abundant amounts of the connexin43 mRNA ( Figure 3 ). This finding suggests that assembly of functional gap junctions between these cells is regulated at a different step 
